← All organizations

Beijing Bionovo Medicine Development Co., Ltd.

For profitWebsite ↗

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Mar 1, 2016

Timeline

2000s

Jan 1, 2003
Beijing Bionovo Medicine Development Co., Ltd.— Founded

Drugs by trial phase (7 distinct, 9 trials)

Phase 4 (5 own, 0 via acquisition)

Phase 3 (1 own, 0 via acquisition)

rasagiline

Phase 2 (1 own, 0 via acquisition)

octohydroaminoacridine

Indications

Studied for

Recent trials (9)

NCT02601222CollaboratorPhase 4Mar 1, 2016
NCT02526225CollaboratorPhase 2Jun 1, 2015
NCT02264535CollaboratorPhase 4Jun 1, 2014
NCT02035111CollaboratorPhase 4Mar 1, 2014
NCT02046031CollaboratorPhase 4Feb 1, 2014
NCT02031523CollaboratorPhase 4Oct 1, 2013
NCT01958957CollaboratorPhase 4Jun 1, 2013
NCT01736891CollaboratorPhase 3Nov 1, 2011
NCT01569516CollaboratorPhase 2Jun 1, 2011

Details

Founded: Beijing, CN Jan 1, 2003
Last known activity: Mar 1, 2016